Breast cancer is the most common cancer in women and the second leading cause of cancer-related deaths after lung cancer.

The FDA has approved Opdivo (nivolumab) in combination with Yervoy (ipilimumab) for unresectable or metastatic microsatellite instability-high or mismatch repair deficient colorectal cancer.

Brain metastases become more prevalent with each line of therapy in metastatic breast cancer and are more common in patients with certain cancer subtypes, new research shows.

If you have metastatic castration-resistant prostate cancer, the hormone therapy you’ve been taking is no longer controlling the disease as it should. Here’s what you should know. This type of ...

well-differentiated pancreatic neuroendocrine tumors (pNET) and extrapancreatic NET (epNET). Specifically, the approval is for those with unresectable, locally advanced, or metastatic pNET and ...

The trigger for facial flushing can range from common conditions like fever, menopause, and changes in body temperatures to uncommon ones like carcinoid syndrome (caused by a rare, slow-growing cancer ...

Exelixis, Inc. (Nasdaq: EXEL) today announced that the U.S. Food and Drug Administration (FDA) has approved CABOMETYX® (cabozantinib) for the treatment of 1) adult and pediatric patients 12 years of ...

Because the cancer cells originated in your prostate gland, the cancer is referred to as metastatic prostate cancer. The cancer cells spread to the bones by breaking away from your prostate gland ...

Camizestrant with a CDK 4/6 inhibitor had a statistically significant and clinically meaningful improvement in PFS in HR+/HER2– advanced breast cancer. Dr. Debu Tripathy breaks down the FDA approval ...

What Is Metastatic Bile Duct Cancer and Its Causes? Bile duct cancer – also called cholangiocarcinoma – is a rare condition. When you have cholangiocarcinoma, cancer cells grow in your bile ...